General AML

ESH 2019 | How can amino acid metabolism drive hematological malignancies?

L:

The AML Global Portal were delighted to speak to Marina Konopleva, MD Anderson Cancer Center, Houston, US, during the European School of Hematology (ESH) Translational Research Conference on AML. We asked Marina Konopleva: How can amino acid metabolism drive hematological malignancies?

She outlined novel concepts to interfere with amino acid metabolism in AML which have partly been pioneered in other hematological  malignancies and which are currently in early clinical development.

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF
Was this article informative? Thank you for your feedback!